A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Clinical trial NCT04885712 · COMPLETED
Trial details
- NCT number
- NCT04885712
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2022-09-19
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.